“This is something that should concern us all … The potential for further spread within Africa and beyond is very worrying,” said WHO director-general Tedros Adhanom Ghebreyesus.
“We are now in a situation where (mpox) poses a risk to many more neighbors in and around central Africa,” said Salim Abdool Karim, a South African infectious diseases expert who chairs the Africa CDC emergency group. He said the new version of mpox spreading from Congo appears to have a death rate of about 3-4%.
Michael Marks, a professor of medicine at the London School of Hygiene and Tropical Medicine, said declaring these latest mpox outbreaks in Africa an emergency is warranted if that might lead to more support to contain them.
“It’s a failure of the global community that things had to get this bad to release the resources needed,” he said.
Jacques Alonda, an epidemiologist working in Congo with international charities, said he and other experts were particularly worried about the spread of mpox in camps for refugees in the country’s conflict-ridden east.
Save the Children said Congo’s health system already had been “collapsing” under the strain of malnutrition, measles and cholera.
Earlier this year, scientists reported the emergence of a new form of the deadlier form of mpox, which can kill up to 10% of people, in a Congolese mining town that they feared might spread more easily. Mpox mostly spreads via close contact with infected people, including through sex.
Before the 2022 outbreak, the disease had mostly been seen in sporadic outbreaks in central and West Africa when people came into close contact with infected wild animals.
Western countries during the 2022 outbreak mostly shut down the spread of mpox with the help of vaccines and treatments, but very few of those have been available in Africa.
Congo hasn’t received any of the mpox vaccines it has requested.
Congolese authorities said they have asked for 4 million doses, Cris Kacita Osako, coordinator of Congo’s Monkeypox Response Committee, told The Associated Press. Kacita Osako said those would mostly be used for children under 18.
Dr. Dimie Ogoina, a Nigerian mpox expert who chaired WHO’s emergency committee, said there were still significant gaps in understanding how mpox is spreading in Africa. He called for stronger surveillance to track the outbreaks.
“We’re working blindly when we’re not able to test all suspected cases,” Ogoina said.
Dr. Boghuma Titanji, an infectious diseases expert at Emory University, said the last WHO emergency declaration for mpox “did very little to move the needle” on getting things like diagnostic tests, medicines and vaccines to Africa.
“The world has a real opportunity here to act in a decisive manner and not repeat past mistakes, (but) that will take more than an (emergency) declaration,” Titanji said.